药物性肝病的诊断与治疗进展  

Progress of diagnosis and treatment of drug-induced liver disease

作　　者：伍百贺[1] 詹俊[1] 

机构地区：[1]中山大学附属第二医院消化内科,510120

出　　处：《国际消化病杂志》2008年第5期413-415,共3页International Journal of Digestive Diseases

摘　　要：药物性肝病(DILD)是指在使用某种或几种药物后,由药物或其代谢产物引起的肝脏损害。随着新药不断研发和应用于临床,药物性肝病的发病率也在逐年增高,引起人们对药物性肝损伤的重视及研究。此文主要就药物性肝病的诊断与治疗进展作一综述。Drug-induced liver disease（DILD）is defined as injury to the liver caused by exposure to a drug or some drugs. As we use more and more new drugs in clinic,the incidence of drug-induced liver disease is increasing year by year. Here we review the progress of diagnosis and treatment of DILD for reference.

关 键 词：药物性肝病 诊断 治疗 

分 类 号：R595.3[医药卫生—内科学]